Researchers at The University of Texas MD Anderson Cancer Center have identified a specific gut bacterium involved in the progression of graft-versus-host disease (GVHD) after antibiotic treatment of allogeneic hematopoietic ...
Sep 29, 2022
0
30
A Ludwig Cancer Research study has identified a combination of three existing drugs that significantly extends survival in mouse models of the lethal brain cancer glioblastoma multiforme (GBM).
Sep 20, 2022
0
40
When the mRNA COVID-19 vaccines were first unveiled in December 2020, medical experts touted the benefits of this new technology, saying formulations could easily be tweaked someday to match a quickly changing virus. That ...
Sep 15, 2022
0
6
U.S. health officials are warning against overuse of the lone drug available to treat monkeypox, saying that even a small mutation in the virus could render the pills ineffective.
Sep 15, 2022
0
30
The procedure had only ever been performed on pigs, doctors told Tayler and Nick Monroe as they huddled over their dying newborn son.
Sep 14, 2022
0
4
Researchers from the University of Georgia have discovered a potential treatment for Chagas disease, marking the first medication with promise to successfully and safely target the parasitic infection in more than 50 years.
Sep 8, 2022
0
106
In animal studies led by researchers at Duke Cancer Institute, a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing the brain.
Aug 31, 2022
0
60
A team of University of British Columbia researchers working on developing oral insulin tablets as a replacement for daily insulin injections have made a game-changing discovery.
Aug 30, 2022
3
249
Tohoku University scientists in Japan have made a scaffold that supports the growth of new bone in large jaw defects in mice. Their findings, published in the journal PNAS Nexus, bring scientists one step closer to addressing ...
Aug 26, 2022
0
46
The benefits of a new COVID-19 booster that targets omicron variants far outweigh the possible risks, experts say.
Aug 25, 2022
0
25
